Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 386

1.

Percutaneous patent foramen ovale closure: outcomes with the Premere and Amplatzer devices.

Bissessor N, Wong AW, Hourigan LA, Jayasinghe RS, Scalia GS, Burstow DJ, Griffiths LR, Savage M, Walters DL.

Cardiovasc Revasc Med. 2011 May-Jun;12(3):164-9. doi: 10.1016/j.carrev.2010.06.001. Epub 2010 Oct 20.

PMID:
21640934
2.

Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.

Elmariah S, Furlan AJ, Reisman M, Burke D, Vardi M, Wimmer NJ, Ling S, Chen X, Kent DM, Massaro J, Mauri L; CLOSURE I Investigators.

JACC Cardiovasc Interv. 2014 Aug;7(8):913-20. doi: 10.1016/j.jcin.2014.01.170.

3.

Long-term follow-up after PFO device closure: Outcomes and Complications in a Single-center Experience.

Taggart NW, Reeder GS, Lennon RJ, Slusser JP, Freund MA, Cabalka AK, Cetta F, Hagler DJ.

Catheter Cardiovasc Interv. 2017 Jan;89(1):124-133. doi: 10.1002/ccd.26518. Epub 2016 Mar 29.

PMID:
27027873
4.
5.

Clinical outcomes of patent foramen ovale closure for paradoxical emboli without echocardiographic guidance.

Varma C, Benson LN, Warr MR, Yeo E, Yip J, Jaigobin CS, Webb G, McLaughlin PR.

Catheter Cardiovasc Interv. 2004 Aug;62(4):519-25.

PMID:
15274165
6.

Long-term experience and outcomes with transcatheter closure of patent foramen ovale.

Inglessis I, Elmariah S, Rengifo-Moreno PA, Margey R, O'Callaghan C, Cruz-Gonzalez I, Baron S, Mehrotra P, Tan TC, Hung J, Demirjian ZN, Buonanno FS, Ning M, Silverman SB, Cubeddu RJ, Pomerantsev E, Schainfeld RM, Dec GW Jr, Palacios IF.

JACC Cardiovasc Interv. 2013 Nov;6(11):1176-83. doi: 10.1016/j.jcin.2013.06.013.

7.

Recurrent events following patent foramen ovale closure in patients above 55 years of age with presumed paradoxical embolism.

Spies C, Khandelwal A, Timmemanns I, Kavinsky CJ, Schräder R, Hijazi ZM.

Catheter Cardiovasc Interv. 2008 Dec 1;72(7):966-70. doi: 10.1002/ccd.21737.

PMID:
18942060
8.

Management of residual shunts after initial percutaneous patent foramen ovale closure: a single center experience with immediate and long-term follow-up.

Diaz T, Cubeddu RJ, Rengifo-Moreno PA, Cruz-Gonzalez I, Solis-Martin J, Buonanno FS, Inglessis I, Palacios IF.

Catheter Cardiovasc Interv. 2010 Jul 1;76(1):145-50. doi: 10.1002/ccd.22475.

PMID:
20578100
9.

Medium-term results of transcatheter closure of patent foramen ovale (PFO) with Amplatzer PFO and Cribriform occluders.

Białkowski J, Wawrzyńczyk M, Karwot B, Fiszer R, Knop M, Szkutnik M.

Kardiol Pol. 2012;70(11):1142-6.

10.

Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism: procedural and follow-up results after implantation of the Amplatzer®-occluder device.

Fischer D, Haentjes J, Klein G, Schieffer B, Drexler H, Meyer GP, Schaefer A.

J Interv Cardiol. 2011 Feb;24(1):85-91. doi: 10.1111/j.1540-8183.2010.00593.x. Epub 2010 Aug 23.

PMID:
20735710
11.

Initial experience with the novel patent foramen ovale occlusion device Nit-Occlud® in patients with stroke or transient ischemic attack.

Steinberg DH, Bertog SC, Momberger J, Franke J, Hofmann I, Renkhoff K, Joy S, Vaskelyte L, Sievert H.

Catheter Cardiovasc Interv. 2015 Jun;85(7):1262-7. doi: 10.1002/ccd.25580. Epub 2015 Apr 2.

PMID:
24948394
12.

The Flatstent versus the conventional umbrella devices in the percutaneous closure of patent foramen ovale.

Aral M, Mullen M.

Catheter Cardiovasc Interv. 2015 May;85(6):1058-65. doi: 10.1002/ccd.25750. Epub 2014 Nov 27.

PMID:
25413379
13.

Transcatheter patent foramen ovale closure is effective in reducing migraine independently from specific interatrial septum anatomy and closure devices design.

Rigatelli G, Cardaioli P, Dell'Avvocata F, Giordan M, Braggion G, Chinaglia M, Roncon L.

Cardiovasc Revasc Med. 2010 Jan-Mar;11(1):29-33. doi: 10.1016/j.carrev.2008.04.002.

PMID:
20129358
14.

Residual shunt after percutaneous closure of patent foramen ovale with AMPLATZER occluder devices - influence of anatomic features: a transcranial Doppler and intracardiac echocardiography study.

Marchese N, Pacilli MA, Inchingolo V, Fanelli R, Loperfido F, Vigna C.

EuroIntervention. 2013 Jul;9(3):382-8. doi: 10.4244/EIJV9I3A61.

15.

Residual shunting after percutaneous PFO closure: how to manage and how to close.

Butera G, Sarabia JF, Saracino A, Chessa M, Piazza L, Carminati M.

Catheter Cardiovasc Interv. 2013 Nov 15;82(6):950-8. doi: 10.1002/ccd.25097. Epub 2013 Jul 30.

PMID:
23804551
16.

Late results after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism using the amplatzer PFO occluder without intraprocedural echocardiography: effect of device size.

Wahl A, Tai T, Praz F, Schwerzmann M, Seiler C, Nedeltchev K, Windecker S, Mattle HP, Meier B.

JACC Cardiovasc Interv. 2009 Feb;2(2):116-23. doi: 10.1016/j.jcin.2008.09.013.

17.

Randomized clinical trial comparing percutaneous closure of patent foramen ovale (PFO) using the Amplatzer PFO Occluder with medical treatment in patients with cryptogenic embolism (PC-Trial): rationale and design.

Khattab AA, Windecker S, Jüni P, Hildick-Smith D, Dudek D, Andersen HR, Ibrahim R, Schuler G, Walton AS, Wahl A, Mattle HP, Meier B.

Trials. 2011 Feb 28;12:56. doi: 10.1186/1745-6215-12-56.

18.

Transcatheter PFO closure with GORE(®) septal occluder: early and mid-term clinical results.

Butera G, Saracino A, Danna P, Sganzerla P, Chessa M, Carminati M.

Catheter Cardiovasc Interv. 2013 Nov 15;82(6):944-9. doi: 10.1002/ccd.25106. Epub 2013 Jul 30.

PMID:
23897659
19.

Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.

Paciaroni M, Agnelli G, Bertolini A, Pezzini A, Padovani A, Caso V, Venti M, Alberti A, Palmiero RA, Cerrato P, Silvestrelli G, Lanari A, Previdi P, Corea F, Balducci A, Ferri R, Falcinelli F, Filippucci E, Chiocchi P, Grandi FC, Ferigo L, Musolino R, Bersano A, Ghione I, Sacco S, Carolei A, Baldi A, Ageno W; FORI (Foramen Ovale Registro Italiano) Investigators.

Cerebrovasc Dis. 2011;31(2):109-16. doi: 10.1159/000321334. Epub 2010 Nov 17.

PMID:
21088390
20.

Efficiency of transcatheter patent foramen ovale closure in children after paradoxical embolism events.

Wawrzyńczyk M, Gałeczka M, Karwot B, Knop M, Białkowski J.

Kardiol Pol. 2016;74(4):385-9. doi: 10.5603/KP.a2015.0194. Epub 2015 Sep 28.

Supplemental Content

Support Center